Integra LifeSciences
1
4M
1
0.03
- Areas of investment
Summary
In 1989 was created Integra LifeSciences, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Plainsboro. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Integra LifeSciences, startups are often financed by Yissum Technology Transfer Company of the Hebrew University, Clal Biotechnology Industries, Technion Research & Development Foundation. The meaningful sponsors for the fund in investment in the same round are Yissum Technology Transfer Company of the Hebrew University. In the next rounds fund is usually obtained by Yissum Technology Transfer Company of the Hebrew University.
This organization was formed by Richard E. Caruso.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The top activity for fund was in 2014. The fund is generally included in less than 2 deals every year.
The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Biotechnology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Avraham Pharmaceuticals, Avraham Pharmaceuticals. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.03
- Investments by industry
- Pharmaceutical (1)
- Health Care (1)
- Biotechnology (1)
- Investments by region
-
- Israel (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.